| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | STAR |
| Uniprot No | P49675 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 64-285aa |
| 氨基酸序列 | MGSSHHHHHHSSGLVPRGSHMEETLYSDQELAYLQQGEEAMQKALGILSN QEGWKKESQQDNGDKVMSKVVPDVGKVFRLEVVVDQPMERLYEELVERME AMGEWNPNVKEIKVLQKIGKDTFITHELAAEAAGNLVGPRDFVSVRCAKR RGSTCVLAGMATDFGNMPEQKGVIRAEHGPTCMVLHPLAGSPSKTKLTWL LSIDLKGWLPKSIINQVLSQTQVDFANHLRKRLESHPASEARC |
| 预测分子量 | 27 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于STAR重组蛋白的3-4条参考文献示例(注：文献标题和作者为虚构示例，仅供格式参考)：
---
1. **文献名称**：Structural and Functional Analysis of STAR Family RNA-Binding Proteins
**作者**：Smith J, et al.
**摘要**：本研究解析了STAR蛋白家族(如Sam68)的RNA结合结构域，揭示了其通过特异性识别靶RNA序列调控基因表达的分子机制，并利用重组蛋白技术验证了关键功能位点。
2. **文献名称**：Optimized Recombinant Expression of STAR Protein Quaking in E. coli
**作者**：Lee H, et al.
**摘要**：通过优化表达载体和宿主条件，成功实现STAR家族蛋白Quaking的高效重组表达与纯化，为研究其在神经发育中的功能提供了可溶性蛋白工具。
3. **文献名称**：Application of STAR Protein-mediated Splicing in Gene Therapy
**作者**：Chen R, et al.
**摘要**：利用重组STAR蛋白(如SF1)调控pre-mRNA剪接的活性，开发了一种新型基因治疗策略，并在体外模型中验证了其对疾病相关剪接异常的纠正能力。
4. **文献名称**：Kinase-dependent Interaction of STAR Protein Domains with Signaling Pathways
**作者**：Wang Y, et al.
**摘要**：通过重组蛋白互作实验，证明STAR蛋白的结构域与MAPK信号通路成分存在磷酸化依赖性结合，提示其在细胞应激响应中的调控作用。
---
以上文献示例展示了STAR重组蛋白在结构解析、表达优化、功能机制及生物医学应用等领域的研究方向。实际引用时需根据具体研究主题检索真实文献。
**Background of STAR Recombinant Proteins**
STAR (Strep-tag II affinity-ranked) recombinant proteins are engineered through a rational design approach to enhance solubility, stability, and purification efficiency while maintaining native functionality. Developed as an alternative to traditional affinity-tagged proteins (e.g., His-tag or GST-tag), STAR technology integrates a small, high-affinity Strep-tag II peptide into surface loops of target proteins. This tag binds reversibly to Strep-Tactin resin, enabling gentle, one-step purification under physiological conditions.
The concept emerged from the need to address challenges in recombinant protein production, such as low yields, aggregation, and loss of activity due to harsh purification methods. By optimizing surface charge and entropy via computational modeling and directed evolution, STAR proteins exhibit improved solubility in *E. coli* expression systems, even for traditionally difficult targets like membrane proteins or large complexes.
A key innovation lies in the non-disruptive placement of the Strep-tag II, which avoids interference with protein folding or functional domains. This feature makes STAR proteins particularly valuable in structural biology (e.g., X-ray crystallography, cryo-EM) and biochemical assays requiring unmodified active sites. Additionally, the technology supports fusion-free designs, eliminating the need for tag cleavage steps that can reduce yields or introduce artifacts.
STAR variants have been adopted in drug discovery, diagnostics, and industrial enzymology, where high-purity, stable proteins are critical. Their compatibility with automated platforms further streamlines workflows in high-throughput applications. By balancing ease of production with functional integrity, STAR recombinant proteins represent a versatile toolset bridging biotechnological innovation and practical research needs.
×
